No Picture
Business News

Alaska’s RavnAir bankruptcy while awaiting government aid shows regional airlines’ challenges

RavnAir Group, the largest regional carrier in Alaska, filed for bankruptcy on Sunday and grounded all of its 72 planes, saying it was clear that government aid would not arrive before it ran out of cash in the midst of an “astonishing” decline in bookings and revenue due to the coronavirus.

…read more […]

No Picture
Trading Ideas

Coronavirus Fighter Gilead Sciences Might Be Expensive, but It’s Still Worth Owning

Gilead Sciences (GILD) has positioned itself at the front line in the global war against COVID-19. The biotech’s experimental drug remdesivir is currently in two Gilead sponsored Phase 3 trials in over 90 locations, and two further investigator sponsored Phase 3 trials in China. The drug is currently registered in 11 ongoing trials, from which a handful of data readouts are expected in the next 2 to 6 weeks.So far, remdesivir has shown powerful in vitro efficacy against RNA viruses in cell-based assays and evidence of efficacy in both in California and Washington states; Additionally, there has also been some …read more […]

No Picture
Trading Ideas

Peloton halts live classes as employee tests positive for COVID-19

Peloton, whose flagship product is a stationary exercise bike priced at over $2,200, had said on Friday an employee at its New York City-based production studio has tested positive for COVID-19, according to a report https://www.theverge.com/2020/4/3/21207751/peloton-live-classes-employee-tested-positive-covid-19 by The Verge. Peloton said https://blog.onepeloton.com/peloton-covid-19-initiatives on Monday it would continue to add new, pre-recorded content on its Peloton App, which has a monthly subscription cost of $12.99. …read more […]